Comparing Methods to Assess Treatment Effect Heterogeneity in General Parametric Regression Models
- 22 January 2026
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 45 (1-2) , e70381
Abstract
This paper reviews and compares methods to assess treatment effect heterogeneity in the context of parametric regression models. These methods include the standard likelihood ratio tests, bootstrap likelihood ratio tests, and Goeman's global test, motivated by testing whether the random effect variance is zero. We place particular emphasis on tests based on the score‐residual of the treatment effect and explore different variants of tests in this class. All approaches are compared in a simulation study, and the approach based on residual scores is illustrated in a clinical trial with a time‐to‐event outcome comparing treatment vs. placebo. Our findings demonstrate that score‐residual‐based methods provide practical, flexible, and reliable tools for exploring treatment effect heterogeneity and treatment effect modifiers, and can provide useful guidance for decision‐making around treatment effect heterogeneity.Keywords
This publication has 28 references indexed in Scilit:
- Using Individualized Treatment Effects to Assess Treatment Effect HeterogeneityStatistics in Medicine, 2025
- WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial SponsorsPharmaceutical Statistics, 2024
- Modern approaches for evaluating treatment effect heterogeneity from clinical trials and observational dataStatistics in Medicine, 2024
- Comparing algorithms for characterizing treatment effect heterogeneity in randomized trialsBiometrical Journal, 2022
- Subgroup identification in dose‐finding trials via model‐based recursive partitioningStatistics in Medicine, 2018
- Evaluation of Evidence of Statistical Support and Corroboration of Subgroup Claims in Randomized Clinical TrialsJAMA Internal Medicine, 2017
- Testing interaction between treatment and high‐dimensional covariates in randomized clinical trialsBiometrical Journal, 2016
- Tutorial in biostatistics: data‐driven subgroup identification and analysis in clinical trialsStatistics in Medicine, 2016
- Explained randomness in proportional hazards modelsStatistics in Medicine, 2004
- Analysis and Interpretation of Treatment Effects in Subgroups of Patients in Randomized Clinical TrialsJAMA, 1991